title: Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza.
authors.forename: Steven Y C
authors.initials: SY
authors.lastname: Tong
authors.forename: Nicholas M
authors.initials: NM
authors.lastname: Anstey
authors.forename: Gary D
authors.initials: GD
authors.lastname: Lum
authors.forename: Rachael A
authors.initials: RA
authors.lastname: Lilliebridge
authors.forename: Dianne P
authors.initials: DP
authors.lastname: Stephens
authors.forename: Bart J
authors.initials: BJ
authors.lastname: Currie
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000235:genetics; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005098:Exotoxins / Q000235:genetics; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007251:Influenza, Human / Q000382:microbiology*; D007956:Leukocidins / Q000235:genetics; D016106:Methicillin Resistance; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D020641:Polymorphism, Single Nucleotide; D012131:Respiratory Insufficiency / Q000209:etiology; D013203:Staphylococcal Infections / Q000150:complications* / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin